AP
Healthcare & Life Sciences
Apertor Pharmaceuticals
Apertor Pharmaceuticals is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Apertor Pharmaceuticals
Apertor Pharmaceuticals is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Apertor Pharmaceuticals is a pharmaceutical company involved in drug development and biopharma, as part of Apple Tree Partners' investment portfolio.
Explore Apertor Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.